← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Dicerna Pharmaceuticals, Inc.
Cambridge, MA
$7,182,738
Total funding
3
Grants
Funding over time
peak $1.5M · FY2015–21$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,182,738 · 3
By mechanism
U44$5,000,000 · 1
R44$1,998,609 · 1
R43$184,129 · 1
Investigators at Dicerna Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of an ALDH2-Targeting RNAi Therapeutic for Alcohol Use Disorders$1,500,000
U44 · FY2021 · AA
Development of an ALDH2-Targeting RNAi Therapeutic for Alcohol Use Disorders$1,500,000
U44 · FY2020 · AA
Development of an ALDH2-Targeting RNAi Therapeutic for Alcohol Use Disorders$1,000,000
U44 · FY2019 · AA
Development of an ALDH2-Targeting RNAi Therapeutic for Alcohol Use Disorders$1,000,000
U44 · FY2018 · AA
Optimization of a clinical stage nanoparticle drug delivery platform$1,000,000
R44 · FY2016 · CA
Optimization of a clinical stage nanoparticle drug delivery platform$998,609
R44 · FY2017 · CA
Optimization of a clinical stage nanoparticle drug delivery platform$184,129
R43 · FY2015 · CA